Literature DB >> 23010559

Risk scores based on self-reported or available clinical data to detect undiagnosed type 2 diabetes: a systematic review.

Nicola Brown1, Julia Critchley, Paul Bogowicz, Mary Mayige, Nigel Unwin.   

Abstract

OBJECTIVE: To systematically review published primary research on the development or validation of risk scores that require only self-reported or available clinical data to identify undiagnosed Type 2 Diabetes Mellitus (T2DM).
METHODS: A systematic literature search of Medline and EMBASE was conducted until January 2011. Studies focusing on the development or validation of risk scores to identify undiagnosed T2DM were included. Risk scores to predict future risk of T2DM were excluded.
RESULTS: Thirty-one studies were included; 17 developed a new risk score, 14 validated existing scores. Twenty-six studies were conducted in high-income countries. Age and measures of body mass/fat distribution were the most commonly used predictor variables. Studies developing new scores performed better than validation studies, with 11 reporting an AUC of >0.80 compared to one validation study. Fourteen validation studies reported sensitivities of <80%. The performance of scores did not differ by the number of variables included or the country setting.
CONCLUSIONS: There is a proliferation of newly developed risk scores using similar variables, which sometimes perform poorly upon external validation. Future research should explore the recalibration, validation and applicability of existing scores to other settings, particularly in low/middle income countries, and on the utility of scores to improve diabetes-related outcomes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23010559     DOI: 10.1016/j.diabres.2012.09.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  28 in total

Review 1.  Policy Implications of Artificial Intelligence and Machine Learning in Diabetes Management.

Authors:  David T Broome; C Beau Hilton; Neil Mehta
Journal:  Curr Diab Rep       Date:  2020-02-01       Impact factor: 4.810

2.  Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants.

Authors:  Manjusha Kulkarni; Randi E Foraker; Ann M McNeill; Cynthia Girman; Sherita H Golden; Wayne D Rosamond; Bruce Duncan; Maria Ines Schmidt; Jaakko Tuomilehto
Journal:  Diabetes Obes Metab       Date:  2017-05-22       Impact factor: 6.577

3.  COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.

Authors:  Laith J Abu-Raddad; Soha Dargham; Hiam Chemaitelly; Peter Coyle; Zaina Al Kanaani; Einas Al Kuwari; Adeel A Butt; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Hadi M Yassine; Mohamed G Al Kuwari; Hamad Eid Al Romaihi; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

4.  Factors associated with untreated diabetes: analysis of data from 20,496 participants in the Japanese National Health and Nutrition Survey.

Authors:  Maki Goto; Atsushi Goto; Nayu Ikeda; Hiroyuki Noda; Kenji Shibuya; Mitsuhiko Noda
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

5.  Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: a systematic review.

Authors:  Katya L Masconi; Tandi E Matsha; Justin B Echouffo-Tcheugui; Rajiv T Erasmus; Andre P Kengne
Journal:  EPMA J       Date:  2015-03-11       Impact factor: 6.543

6.  Independent external validation and comparison of prevalent diabetes risk prediction models in a mixed-ancestry population of South Africa.

Authors:  Katya Masconi; Tandi E Matsha; Rajiv T Erasmus; Andre P Kengne
Journal:  Diabetol Metab Syndr       Date:  2015-05-09       Impact factor: 3.320

7.  Risk-benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes.

Authors:  Juliana Cn Chan
Journal:  J Diabetes Investig       Date:  2013-04-26       Impact factor: 4.232

8.  Predicting youth diabetes risk using NHANES data and machine learning.

Authors:  Nita Vangeepuram; Bian Liu; Po-Hsiang Chiu; Linhua Wang; Gaurav Pandey
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

9.  Effects of Different Missing Data Imputation Techniques on the Performance of Undiagnosed Diabetes Risk Prediction Models in a Mixed-Ancestry Population of South Africa.

Authors:  Katya L Masconi; Tandi E Matsha; Rajiv T Erasmus; Andre P Kengne
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.

Authors:  Miguel Ángel Salinero-Fort; Carmen de Burgos-Lunar; José Mostaza Prieto; Carlos Lahoz Rallo; Juan Carlos Abánades-Herranz; Paloma Gómez-Campelo; Fernando Laguna Cuesta; Eva Estirado De Cabo; Francisca García Iglesias; Teresa González Alegre; Belén Fernández Puntero; Luis Montesano Sánchez; David Vicent López; Víctor Cornejo Del Río; Pedro J Fernández García; Concesa Sabín Rodríguez; Silvia López López; Pedro Patrón Barandío
Journal:  BMJ Open       Date:  2015-07-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.